Skip to main content
. Author manuscript; available in PMC: 2015 Aug 8.
Published in final edited form as: Breast Cancer Res Treat. 2014 Aug 8;147(1):145–158. doi: 10.1007/s10549-014-3071-y

Table 2.

Associations between JAK/STAT genes and risk of breast cancer by genetic ancestry and Estrogen and Progesterone Receptor Tumor Phenotype.


Overall ≤28% IA Ancestry >28–70% IA Ancestry >70% IA Ancestry

Controls Cases OR2 (95% CI) Controls Cases OR (95% CI) Controls Cases OR (95% CI) Controls Cases OR (95% CI)

STAT5B (rs6503691)
 CC 3378 2897 1.00 1473 1383 1.00 1350 1115 1.00 555 399 1.00
 CT/TT 779 672 0.98 (0.87, 1.10) 374 359 1.01 (0.86, 1.19) 331 275 1.01 (0.84, 1.21) 74 38 0.63 (0.41, 0.97)
 P-value (raw; adjusted) 0.713, 1.000 0.906, 0.906 0.938, 1.000 0.035, 0.069
STAT6 (rs3024974)
 CC 3435 2868 1.00 1507 1394 1.00 1384 1097 1.00 544 377 1.00
 CT/TT 720 698 1.15 (1.02, 1.29) 340 346 1.10 (0.93, 1.30) 295 292 1.25 (1.04, 1.50) 85 60 1.01 (0.70, 1.46)
 P-value (raw; adjusted) 0.018, 0.072 0.268, 1.000 0.017, 0.068 0.953, 1.000
TYK2 (rs280519)
 AA 1499 1265 1.00 476 439 1.00 681 562 1.00 342 264 1.00
 AG/GG 2651 2289 0.96 (0.87, 1.06) 1371 1295 1.03 (0.89, 1.20) 995 821 0.98 (0.84, 1.13) 285 173 0.75 (0.58, 0.96)
 P-value (raw; adjusted) 0.416, 1.000 0.704, 1.000 0.766, 1.000 0.025, 0.093

ER+/PR+ ER+/PR− ER−/PR+ ER−/PR−

JAK2 (rs1536800)
 CC 1798 764 1.00 122 1.00 26 1.00 263 1.00
 CT/TT 1374 533 0.92 (0.81, 1.05) 113 1.22 (0.93, 1.59) 17 0.85 (0.46, 1.57) 152 0.75 (0.61, 0.93)
 P-value (raw; adjusted) 0.225, 1.000 0.150, 0.899 0.595, 1.000 0.009, 0.053
STAT3 (rs8069645)1
 AA 1872 756 1.00 133 1.00 18 1.00 253 1.00
 AG 1119 468 1.00 (0.87, 1.15) 94 1.16 (0.88, 1.53) 19 1.91 (0.99, 3.68) 144 0.96 (0.77, 1.20)
 GG 181 74 0.94 (0.70, 1.25) 8 0.58 (0.28, 1.21) 6 3.79 (1.46, 9.84) 18 0.74 (0.44, 1.22)
 P-value (raw; adjusted) 0.785, 0.959 0.831, 1.000 0.004, 0.010 0.324, 0.882
STAT3 (rs6503695)
 TT 1662 672 1.00 117 1.00 17 1.00 222 1.00
 TC 1256 519 0.98 (0.85, 1.12) 106 1.17 (0.88, 1.55) 19 1.63 (0.83, 3.19) 164 0.99 (0.79, 1.23)
 CC 255 106 0.93 (0.73, 1.19) 12 0.62 (0.33, 1.14) 7 3.10 (1.23, 7.81) 28 0.83 (0.54, 1.26)
 P-value (raw; adjusted) 0.564, 0.959 0.687, 1.000 0.016, 0.029 0.507, 0.882
STAT3 (rs12949918)
 TT 1428 578 1.00 109 1.00 13 1.00 197 1.00
 TC 1371 573 0.98 (0.85, 1.13) 97 0.90 (0.67, 1.21) 23 2.07 (1.03, 4.19) 171 0.92 (0.73, 1.15)
 CC 372 147 0.88 (0.71, 1.10) 29 0.95 (0.61, 1.47) 7 2.47 (0.94, 6.47) 46 0.91 (0.64, 1.29)
 P-value (raw; adjusted) 0.344, 0.959 0.631, 1.000 0.030, 0.030 0.454, 0.882
STAT3 (rs1026916)
 GG 1550 636 1.00 119 1.00 14 1.00 215 1.00
 GA/AA 1622 662 0.96 (0.84, 1.09) 116 0.91 (0.69, 1.19) 29 2.13 (1.11, 4.09) 200 0.90 (0.73, 1.11)
 P-value (raw; adjusted) 0.522, 0.959 0.488, 1.000 0.024, 0.029 0.317, 0.882
STAT5A (rs7217728)1
 TT 1836 740 1.00 130 1.00 16 1.00 247 1.00
 TC/CC 1335 557 0.99 (0.87, 1.13) 105 1.09 (0.83, 1.43) 27 2.5 (1.32, 4.72) 168 0.94 (0.76, 1.17)
 P-value (raw; adjusted) 0.920, 0.920 0.533, 0.835 0.005, 0.007 0.600, 0.600
STAT5A (rs12601982)
 AA 2364 945 1.00 174 1.00 26 1.00 320 1.00
 AG/GG 806 353 1.06 (0.91, 1.22) 61 1.00 (0.74, 1.36) 17 2.03 (1.08, 3.80) 95 0.88 (0.69, 1.12)
 P-value (raw; adjusted) 0.479, 0.750 0.980, 0.980 0.027, 0.027 0.294, 0.461
STAT5B (rs7218653)1
 AA 1849 745 1.00 132 1.00 15 1.00 237 1.00
 AG/GG 1323 553 1.00 (0.87, 1.14) 103 1.07 (0.81, 1.40) 28 2.85 (1.49, 5.43) 178 1.07 (0.86, 1.32)
 P-value (raw; adjusted) 0.946, 0.958 0.631, 0.631 0.002, 0.003 0.541, 0.541
1

p values for difference by ER/PR group after adjustment for multiple comparisons were 0.07, 0.05, and 0.04 respectively

2

Odds ratios (OR) and 95% confidence Intervals (CI) adjusted for age, study center, BMI during referent year, parity, and genetic ancestry. Risk estimates are shown in the table if one or more of the adjusted p values for multiple comparisons is <0.15.